DermTech Future Growth
Future criteria checks 2/6
DermTech is forecast to grow earnings and revenue by 14.2% and 29.4% per annum respectively while EPS is expected to grow by 27.7% per annum.
Key information
14.2%
Earnings growth rate
27.7%
EPS growth rate
Biotechs earnings growth | 0% |
Revenue growth rate | 29.4% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 18 Aug 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 30 | -87 | N/A | N/A | 3 |
12/31/2024 | 20 | -91 | N/A | N/A | 6 |
12/31/2023 | 16 | -110 | N/A | N/A | 6 |
6/30/2023 | 14 | -120 | -94 | -91 | N/A |
3/31/2023 | 14 | -118 | -96 | -92 | N/A |
12/31/2022 | 15 | -117 | -99 | -95 | N/A |
9/30/2022 | 15 | -115 | -99 | -97 | N/A |
6/30/2022 | 14 | -106 | -91 | -88 | N/A |
3/31/2022 | 13 | -93 | -80 | -76 | N/A |
12/31/2021 | 12 | -78 | -65 | -62 | N/A |
9/30/2021 | 11 | -63 | -48 | -46 | N/A |
6/30/2021 | 9 | -52 | -40 | -38 | N/A |
3/31/2021 | 7 | -45 | -34 | -32 | N/A |
12/31/2020 | 6 | -36 | -31 | -29 | N/A |
9/30/2020 | 5 | -31 | -30 | -28 | N/A |
6/30/2020 | 5 | -27 | -28 | -26 | N/A |
3/31/2020 | 4 | -21 | -23 | -22 | N/A |
12/31/2019 | 3 | -20 | -18 | -18 | N/A |
9/30/2019 | 2 | -18 | -13 | -13 | N/A |
6/30/2019 | 2 | -14 | -9 | -8 | N/A |
3/31/2019 | 3 | -13 | -8 | -8 | N/A |
12/31/2018 | 2 | -10 | -8 | -8 | N/A |
12/31/2017 | 2 | -8 | -6 | -6 | N/A |
6/30/2014 | 0 | -6 | N/A | -4 | N/A |
3/31/2014 | 0 | -6 | N/A | -3 | N/A |
12/31/2013 | N/A | -5 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DMTK * is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: DMTK * is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: DMTK * is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: DMTK *'s revenue (29.4% per year) is forecast to grow faster than the MX market (6.2% per year).
High Growth Revenue: DMTK *'s revenue (29.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DMTK *'s Return on Equity is forecast to be high in 3 years time